Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
28.02 EUR
-0.39%
Market Closed
Updated:
May 3, 2024
Bayer AG
Depreciation & Amortization
|
Bayer AG
Depreciation & Amortization Peer Comparison
Comparables:
ATAI
MRK
93M1
DMP
PSG
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bayer AG
XETRA:BAYN
|
Depreciation & Amortization
€10B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Depreciation & Amortization
$319k
|
CAGR 3-Years
152%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Depreciation & Amortization
€1.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Depreciation & Amortization
€25.2k
|
CAGR 3-Years
31%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Depreciation & Amortization
€101.8m
|
CAGR 3-Years
32%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Depreciation & Amortization
€9.3m
|
CAGR 3-Years
186%
|
CAGR 5-Years
86%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Depreciation & Amortization?
Depreciation & Amortization
10B
EUR
10B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Depreciation & Amortization amounts to 10B EUR.
What is Bayer AG's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
13%
13%
Over the last year, the Depreciation & Amortization growth was 54%. The average annual Depreciation & Amortization growth rates for Bayer AG have been -9% over the past three years , 10% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
